A Clinical trial comparing the effect of two drugs Levobupivacaine and ropivacaine in elective casarean section.
Not Applicable
- Conditions
- Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium
- Registration Number
- CTRI/2023/07/054695
- Lead Sponsor
- JSSAHER
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Adults of ASA physical status II aged 18 to 40 years with gestational age between 37-42 weeks undergoing elective caesarean section.
Exclusion Criteria
Patient refusal
Multiple pregnancy
BMI > 30
Patients with known history of pregnancy induced hypertension, Gestational diabetes mellitus.
•Spinal deformity
•Bleeding disorder
•Acute cardiovascular or respiratory disease
•History of allergy or sensitivity to amide group of local anaesthetic
•Psychiatric disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Time of onset, maximum height and duration of sensory and motor blockade.Timepoint: STARTING FROM SPINAL ANAESTHESIA TILL 24 HOURS AFTER COMPLETION OF SURGERY
- Secondary Outcome Measures
Name Time Method a)To assess the hemodynamic status-Heart rate, Systolic blood pressure, Diastolic blood pressure, Mean arterial pressure <br/ ><br> <br/ ><br>b)To assess neonatal outcome (APGAR at 1min, 5min)Timepoint: STARTING FROM SPINAL ANAESTHESIA TILL 24 HOURS AFTER COMPLETION OF SURGERY